Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

Neyssa Marina, Lisa A. Teot, Pancras C.W. Hogendoorn et al.|The Lancet Oncology|2016

Cited by 537